MX2009011801A - Composiciones para reducir, aminorar, tratar o evitar afeccion de ojo seco y metodos para elaboracion y uso de las mismas. - Google Patents

Composiciones para reducir, aminorar, tratar o evitar afeccion de ojo seco y metodos para elaboracion y uso de las mismas.

Info

Publication number
MX2009011801A
MX2009011801A MX2009011801A MX2009011801A MX2009011801A MX 2009011801 A MX2009011801 A MX 2009011801A MX 2009011801 A MX2009011801 A MX 2009011801A MX 2009011801 A MX2009011801 A MX 2009011801A MX 2009011801 A MX2009011801 A MX 2009011801A
Authority
MX
Mexico
Prior art keywords
compositions
dry eye
ameliorating
treating
reducing
Prior art date
Application number
MX2009011801A
Other languages
English (en)
Inventor
Alyce K Dobie
Erning Xia
Tammy J Kleiber
Original Assignee
Baush & Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baush & Lomb Inc filed Critical Baush & Lomb Inc
Publication of MX2009011801A publication Critical patent/MX2009011801A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Se proporcionan composiciones para el alivio, tratamiento o prevención de una afección de ojo seco que comprende alginato, un poliol y combinaciones de por lo menos dos ácidos orgánicos o sales de los mismos, en donde las composiciones tienen un pH en el intervalo de aproximadamente 5 a aproximadamente 7.5, por lo menos uno de los ácidos orgánicos o sales del mismo tiene una pKa en el intervalo de 6 a aproximadamente 10. En algunas modalidades, el segundo ácido orgánico o una sal del mismo tiene una pKa que es no mayor de 1.5 unidades menor que el pH.
MX2009011801A 2007-05-04 2008-05-01 Composiciones para reducir, aminorar, tratar o evitar afeccion de ojo seco y metodos para elaboracion y uso de las mismas. MX2009011801A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91604607P 2007-05-04 2007-05-04
PCT/US2008/062141 WO2008137496A1 (en) 2007-05-04 2008-05-01 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same

Publications (1)

Publication Number Publication Date
MX2009011801A true MX2009011801A (es) 2009-11-13

Family

ID=39580102

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011801A MX2009011801A (es) 2007-05-04 2008-05-01 Composiciones para reducir, aminorar, tratar o evitar afeccion de ojo seco y metodos para elaboracion y uso de las mismas.

Country Status (7)

Country Link
US (1) US20080275000A1 (es)
EP (1) EP2155162B1 (es)
CN (1) CN101674807B (es)
CA (1) CA2685230C (es)
ES (1) ES2396999T3 (es)
MX (1) MX2009011801A (es)
WO (1) WO2008137496A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201519450D0 (en) * 2015-11-03 2015-12-16 Univ Liverpool Novel treatment
US20220160668A1 (en) 2020-11-23 2022-05-26 Sight Sciences, Inc. Formulations and methods for treating conditions of the eye

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409205A (en) 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4396625A (en) * 1980-05-13 1983-08-02 Sumitomo Chemical Company, Limited Treatment of glaucoma or ocular hypertension and ophthalmic composition
US5209927A (en) 1985-01-23 1993-05-11 Alcon Laboratories, Inc. Ophthalmic solution
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
DE69115990T2 (de) 1990-05-29 1996-05-30 Ocular Res Of Bonton Inc Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
IL114193A (en) * 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
JP4167728B2 (ja) * 1996-02-07 2008-10-22 ロート製薬株式会社 粘度を調節した眼科用組成物
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US6379688B2 (en) 1997-02-28 2002-04-30 Senju Pharmaceutical Co., Ltd. Preservative for emulsion and emulsion containing same
KR100691545B1 (ko) * 1998-09-28 2007-03-09 산텐 세이야꾸 가부시키가이샤 나트륨 이뇨 펩티드를 유효 성분으로하는 누액 분비 촉진또는 각결막 장해 치료용 점안제
IT1306123B1 (it) * 1999-04-02 2001-05-30 Technopharma Sa Soluzione oftalmica viscosizzata con azione detergente sulle lenti acontatto.
JP3502574B2 (ja) * 1999-06-29 2004-03-02 東亜薬品株式会社 眼感染症治療用眼軟膏剤
WO2001007419A1 (fr) * 1999-07-26 2001-02-01 Santen Pharmaceutical Co., Ltd. Nouveaux dérivés de la thiazine ou de la pyrazine
WO2001017527A1 (fr) * 1999-09-06 2001-03-15 Ono Pharmaceutical Co., Ltd. Agents destines a la prevention et a au traitement des maladies des yeux
US6787151B2 (en) * 2001-08-10 2004-09-07 Lipton, Division Of Conopco, Inc. Composition for lowering blood cholesterol
TW200400055A (en) * 2002-02-22 2004-01-01 Pharmacia Corp Ophthalmic formulation with novel gum composition
US6806364B2 (en) * 2002-07-29 2004-10-19 Ast Products, Inc. Ophthalmic compositions
US7037469B2 (en) * 2003-03-19 2006-05-02 Bausch & Lomb, Inc. Method and composition for reducing contact lens swelling
US6930077B2 (en) * 2003-09-10 2005-08-16 Advanced Medical Optics, Inc. Compositions and methods using sub-PPM combinations of polyquaternium-1 and high molecular weight PHMB
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法
US20070004672A1 (en) 2005-07-01 2007-01-04 Dharmendra Jani Long lasting alginate dry eye, related methods of manufacture and methods of use

Also Published As

Publication number Publication date
CA2685230A1 (en) 2008-11-13
EP2155162A1 (en) 2010-02-24
CA2685230C (en) 2012-10-16
CN101674807A (zh) 2010-03-17
US20080275000A1 (en) 2008-11-06
ES2396999T3 (es) 2013-03-01
WO2008137496A1 (en) 2008-11-13
EP2155162B1 (en) 2012-11-21
CN101674807B (zh) 2013-03-20

Similar Documents

Publication Publication Date Title
EP1911454A4 (en) COMPOSITION AND METHOD FOR REGULATING AND MAINTAINING VAGINAL BACTERIA FLORA AND NORMAL ACIDITY IN VAGINA
WO2010074588A8 (en) Pharmaceutical compounds
WO2009146540A8 (en) N-piperidinyl acetamide derivatives as calcium channel blockers
WO2010048087A3 (en) Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
WO2008131860A3 (de) Pyridoncarboxamide, diese enthaltende nutzpflanzenschützende mittel und verfahren zu ihrer herstellung und deren verwendung
TN2011000413A1 (en) Sglt-2inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus impaired glucose tolerance or hyperglycemia
WO2008060359A3 (en) Biodegradable ocular implants and methods for treating ocular conditions
IN2014CN03524A (es)
MX2009010070A (es) Composiciones y metodos para controlar el crecimiento de microorganismos en sistemas acuosos.
AR065033A1 (es) Metodos para prevenir y tratar trastornos neurodegenerativos
EP2428211A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF NEURAL DAMAGE AND NEUROLOGICAL DISEASES
WO2008011478A3 (en) Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
WO2010088450A3 (en) Arylamide derivatives useful in the treatment of diseases associated with serca activity
FI2034956T4 (fi) Matalan viskositeetin omaavia glykosaminoglykaaneja käsittäviä koostumuksia ja mainitun koostumuksen käyttö kroonisen kystiitin terapiassa
PH12019501469A1 (en) Compositions and methods for treating biofilms
WO2008086452A3 (en) Treatment and prevention of alzheimer's disease
WO2011067721A3 (en) Treatment of water
WO2007014253A3 (en) Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure
MX2009007384A (es) Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa.
WO2023129933A3 (en) 6,6-fused heterocyclic compounds as mettl3 inhibitors
MX2009004142A (es) Metodo para prevenir o tratar sindrome metabolico.
MX2009011801A (es) Composiciones para reducir, aminorar, tratar o evitar afeccion de ojo seco y metodos para elaboracion y uso de las mismas.
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
WO2017069820A3 (en) Antimicrobial composition having efficacy against endospores
MX339004B (es) Composiciones para el tratamiento de sistemas de agua.

Legal Events

Date Code Title Description
FG Grant or registration